Published in Cancer Weekly, February 10th, 2009
The research -- which ridded 90 percent of mice of an aggressive form of melanoma that would usually kill the rodents within 25 days -- represents the most effective demonstration to date of a cancer vaccine.
Harvard's David J. Mooney and colleagues describe the research in the current issue of the journal Nature Materials.
"Our immune systems work by recognizing and attacking foreign invaders, allowing most cancer cells -- which...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-02-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.